Back

TSC2 acting as a transcription factor for miR-514b-3p and regulating PI3K-AKT-MTOR pathway via nucleus

Gupta, S.; Mahajan, N.; Kumar, M.; Kumar, A.

2026-03-12 cancer biology
10.64898/2026.03.10.710871 bioRxiv
Show abstract

The PI3K-AKT-MTOR signalling axis is pivotal in regulating cell survival, proliferation, and growth. TSC2 (tuberous sclerosis complex subunit 2) is a well-established negative regulator of this pathway, which primarily acts by suppressing the MTORC1 activity. While the cytoplasmic role of TSC2 is well characterized, emerging evidence suggests its additional nuclear functions. Previous work from our laboratory identified TSC2 as a transcriptional repressor of the EREG (Epiregulin) gene. Building on this foundation, the present study investigates the transcriptional role of TSC2 in miRNA (microRNA) gene regulation. A genome-wide miRNA microarray profiling of TSC2-depleted cells from an oral squamous cell carcinoma (OSCC) cell line, SCC131, identified 19 upregulated and 24 downregulated miRNAs. Of them, miR-514b-3p emerged as one of the most significantly upregulated miRNAs. TSC2 knockdown resulted in robust miR-514b-3p upregulation, whereas TSC2 overexpression suppressed its expression. Moreover, TSC2 negatively regulates MIR514B promoter activity in an NLS-dependent manner. The chromatin immunoprecipitation analysis showed direct binding between TSC2 and MIR514B promoter, establishing miR-514b-3p as a transcriptional target of TSC2. We further identified TSPAN9 (Tetraspanin 9) as a direct downstream target of miR-514b-3p. The dual-luciferase reporter assay and Western blot analysis confirmed direct interaction between miR-514b-3p and TSPAN9 3UTR. Furthermore, TSC2 positively regulates TSPAN9 levels by repressing miR-514b-3p, thereby establishing a novel TSC2-miR-514b-3p-TSPAN9 regulatory axis. Additionally, we uncovered crosstalk between TSC2-miR-514b-3p-TSPAN9 axis and the canonical PI3K-AKT-MTOR signalling, where miR-514b-3p positively, and TSPAN9 negatively regulates the PI3K-AKT-MTOR pathway. Interestingly, AKT functions as an upstream regulator of this axis by modulating TSC2 nuclear localization. Collectively, this study provides new insights into the non-canonical, nucleus-dependent transcriptional functions of TSC2, thus expanding its role beyond cytoplasmic signalling regulation and underscoring its significance in the cellular signalling networks.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3102 papers in training set
Top 3%
12.7%
2
Cell Communication and Signaling
35 papers in training set
Top 0.1%
10.1%
3
PLOS ONE
4510 papers in training set
Top 36%
4.0%
4
International Journal of Molecular Sciences
453 papers in training set
Top 3%
3.6%
5
eLife
5422 papers in training set
Top 25%
3.6%
6
Oncogene
76 papers in training set
Top 0.5%
3.6%
7
Nucleic Acids Research
1128 papers in training set
Top 6%
3.6%
8
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
3.6%
9
Cancers
200 papers in training set
Top 2%
2.6%
10
Cell Death & Disease
126 papers in training set
Top 0.6%
2.1%
11
Journal of Cell Science
353 papers in training set
Top 0.9%
1.9%
50% of probability mass above
12
Communications Biology
886 papers in training set
Top 8%
1.7%
13
Molecular Cancer
14 papers in training set
Top 0.3%
1.7%
14
iScience
1063 papers in training set
Top 16%
1.7%
15
PLOS Genetics
756 papers in training set
Top 10%
1.5%
16
PeerJ
261 papers in training set
Top 9%
1.3%
17
Nature Communications
4913 papers in training set
Top 56%
1.2%
18
BMC Cancer
52 papers in training set
Top 2%
1.2%
19
Cancer Research
116 papers in training set
Top 3%
1.2%
20
Molecular Cancer Research
42 papers in training set
Top 0.5%
1.2%
21
npj Genomic Medicine
33 papers in training set
Top 0.6%
1.0%
22
Journal of Biological Chemistry
641 papers in training set
Top 3%
1.0%
23
Molecular Oncology
50 papers in training set
Top 0.8%
0.9%
24
Journal of Proteome Research
215 papers in training set
Top 2%
0.9%
25
Cell Death Discovery
51 papers in training set
Top 1%
0.9%
26
The FEBS Journal
78 papers in training set
Top 0.7%
0.9%
27
Cell Reports
1338 papers in training set
Top 32%
0.8%
28
Clinical and Translational Medicine
30 papers in training set
Top 0.9%
0.8%
29
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
28 papers in training set
Top 0.4%
0.8%
30
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.8%